Novartis India is up in arms against a two-month old decision of the National Pharmaceutical Pricing Authority (NPPA) to reduce the price of its flagship brand Voveran on public interest grounds.
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/novartis-challenges-nppa-over-voveran-price-fixing
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/business-standard
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/patents
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
